<DOC>
	<DOCNO>NCT02588404</DOCNO>
	<brief_summary>The objective study evaluate predictive value TMPRSS2-ERG gene fusion patient prostate cancer treat radiation hormonal therapy .</brief_summary>
	<brief_title>The Predictive Value TMPRSS2-ERG Fusion High Risk Prostate Cancer Patient</brief_title>
	<detailed_description>The objective study evaluate predictive value TMPRSS2-ERG gene fusion prostate patient treat hormonal radiation treatment biochemical failure Original biopsy slide 65 patient collect review . A tissue use test map DNA fragment construct patient underwent radiation therapy . RNA DNA extract slide . This study , positive , establish predictive value TMPRSS2-ERG gene fusion prostate cancer patient . It lead believe high-risk prostate cancer patient benefit aggressive treatment . An endpoint study evaluate relation Gleason score TMPRSS2-ERG gene fusion . Another evaluate relation T-stage TMPRSS2-ERG gene fusion .</detailed_description>
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<criteria>One follow T3a + PSA &gt; 20 Gleason 8 high Karnofsky performance status â‰¥ 70 . Signed studyspecific inform consent</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
</DOC>